Astrelis
Dialysis facility · MO

DIALYSIS 262520

CCN 262520Latest FY 2022
Historical record. CMS lists this CCN as terminated (voluntary - merger/closure). No successor CCN is recorded. The financials below are the historical results reported under this number and are excluded from current peer comparisons and state counts.
Cost-report basis
HCRIS · as filed
Not audited by Astrelis

Operating margin: -14.8% in FY2022. Days cash on hand: -623 days in FY2022. Total operating revenue: $1.0M in FY2022. Total margin (including nonoperating): -13.7% in FY2022. Figures as filed; not audited by Astrelis.

The read

A dialysis facility in MO. It ran an operating loss of 14.8% in FY22 on $1.0M of operating revenue. It held -623 days of cash on hand — an Astrelis calculation outside expected range, shown at the chart boundary and ranked in its pool. Operating margin declined from -8.6% in FY20 to -14.8% in FY22, though it rose 6.4 points in the most recent year.

Operating margin · FY22
-14.8%
Astrelis calculation · as-filed inputs
▲ 6.4 pts vs FY21
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY22)
Days cash on hand · FY22
-623d
all sources
Astrelis calculation · as-filed inputs
▼ 77 days vs FY21
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY22)
Total operating revenue · FY22
$1.0M
Astrelis calculation · as-filed inputs
▼ $0.1M vs FY21
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY22)
Total margin · incl. nonoperating · FY22
-13.7%
Astrelis calculation · as-filed inputs
▲ 6.5 pts vs FY21
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY22)

The money

$ thousands · HCRIS cost-report basis · as filed, QA-gated

Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio computes only when every input is reported in the filing (otherwise its cell states which input is Not reported in source); a year whose balance sheet does not reconcile is labeled, and its derived ratios read Astrelis calculation unavailable. Not audited by Astrelis.

Operating margin
-14.8% (FY22)
Operating income ÷ total operating revenue
Astrelis calculation · HCRIS WS G-3
Total margin
-13.7% (FY22)
Net income ÷ total revenue incl. nonoperating
Astrelis calculation · HCRIS WS G-3
Days cash on hand
-623d (FY22)
Cash & investments ÷ daily operating expense
Astrelis calculation · HCRIS WS G / G-3
Current ratio
Astrelis calculation unavailable — the filed balance sheet does not reconcile as filed (statement values shown unchanged)
Total current assets ÷ current liabilities
Astrelis calculation · HCRIS WS G
Equity financing ratio
Astrelis calculation unavailable — the filed balance sheet does not reconcile as filed (statement values shown unchanged)
Total net assets ÷ total assets
Astrelis calculation · HCRIS WS G
Days in net patient A/R
Astrelis calculation unavailable — the filed balance sheet does not reconcile as filed (statement values shown unchanged)
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
Astrelis calculation · HCRIS WS G / G-3
$ in thousands
Line itemFY20FY21FY22 · 335 days
Patient revenue1,2341,089991
Total operating revenue1,2341,089991
Total operating expenses1,3401,3211,138
Operating income(106)(232)(147)
Operating margin %-8.6%-21.3%-14.8%
Other non-operating, net281010
Net income(78)(222)(137)
Net income %-6.2%-20.2%-13.7%
— = Not reported in source for that year.
HCRIS CMS-265 cost report · $ thousands · FY20–FY22 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
Display states. FY20 · Days cash on hand: -471 days — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (outside the 0–1,500-day expected range — a valid filing can produce this; the pool absorbs it)FY21 · Days cash on hand: -546 days — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (outside the 0–1,500-day expected range — a valid filing can produce this; the pool absorbs it)FY22 · Days cash on hand: -623 days — Astrelis calculation · outside expected range; shown at the chart boundary and not in peer statistics (this year is not comparison-eligible) (outside the 0–1,500-day expected range — a valid filing can produce this; this year enters no peer pool)

How it operates

quality & operational context · CMS public reporting

The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by provenance class and public source; descriptive context only, never a ranking or adequacy claim. Provenance labels: Reported value is copied from the named public source; Astrelis calculation is a formula applied to unchanged reported inputs, with the formula shown; Illustrative estimate is a benchmark gap, multiplier, or scenario — never a measurement.

Total treatments
3,689
Reported value2022
HCRIS CMS-265
Cost per treatment ($)
308.62
Astrelis calculation2022
HCRIS CMS-265
Net revenue per treatment ($)
268.73
Astrelis calculation2022
HCRIS CMS-265

Trajectory

Cost-report basis · 3 reporting years
Operating margin
-8.6%-21.3%-14.8%FY20FY21FY22
Days cash on hand
-471 days-546 days-623 daysFY20FY21FY22

State context

Missouri
County-level statistics: linkage not established — this record's county mapping is not verified in the resolved spine, and we never place a facility in a county by guesswork. State-level context appears here once a state aggregate layer lands.
Operating margin (as filed)FY22Astrelis calculation

-14.8% operating margin in FY22.

The Board Briefing

Operating margin improved 6.4 points vs FY21 — the briefing traces why, line by line.

Reserve The Board Briefing →
Report coverage: Historical Facility Benchmark. 7 of 10 facility measures available from public sources. This CCN is terminated. The report benchmarks the record's final filed years against their own contemporaneous peer pools and says so on every exhibit; no current-year comparison is implied. The refund guarantee stands: if we cannot deliver the published scope, you pay nothing.

Portfolio Performance Review

A roster-priced triage of the per-facility benchmarks: every facility on your roster, benchmarked and sorted. Requires only a CCN roster.

From $7,500Founding Edition · built to order, first edition · priced by roster size · invoice after coverage confirmation · within 30 days
Request: scoped and quoted before any invoice. No payment is collected on this site.

Cite this page

release 2321a4fc37a7 · 2026-10-22

Astrelis Atlas, "Dialysis 262520", https://astrelis.co/providers/dialysis/262520, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Machine-readable twin of this page: astrelis.co/providers/dialysis/262520.md (Markdown, the same figures with their fiscal years, pools and definitions). Last modified: release 2321a4fc37a7, 2026-10-22. Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.

build 2321a4fc37a7 · 2026-10-22 · dev